Amgen Inc. discovers, develops, manufactures and delivers innovative human therapeutics worldwide, focusing on biotechnology to treat serious illnesses in oncology, inflammation, cardiovascular disease, bone health, nephrology, neuroscience…
HQ: Thousand Oaks, CA, United States of Americawww.amgen.com
USD377.35-1.34%vs prev. close
Market snapshot
Price
USD377.35
Daily move
-1.34%
P/E
23.4
EPS TTM
16.11
Dividend yield
2.64%
Beta
0.43
Market cap
204.0B
Price history
AMGN price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Amgen
AMGN
Drug Manufacturers - General
204.0
23.4
2.64%
-13.7%
-9.3%
+6.2%
+3.0%
+33.5%
+15.3%
🔒
Subscribe to Equity Analytics to compare AMGN with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.